Complete atrio-ventricular septal defects (CAVSD) are present in about 3% of children born with congenital heart pathologies. They usually require early surgical correction, mostly in infancy, and surgery is considered to be the gold standard. It is unlikely that anyone would survive beyond the first years without severe morbidity. However, we report a case of a Pakistani girl who underwent suc...

Division of Cardiovascular and Thoracic Surgery, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA; Department of Cardiothoracic and Vascular Surgery, Cleveland Clinic Foundation, Cleveland, OH, USA Correspondence to: Harold M. Burkhart, MD. Professor and Chief, Division of Cardiovascular and Thoracic Surgery, University of Oklahoma Health Sciences Center, P.O. Box 26901, WP...

Motivated by the inadequacy of nonsurgical therapy in ameliorating congenital cardiac disease, surgical pioneers in the 1940s and 1950s began to develop techniques that would allow for the intracardiac repair of congenital heart disease. The fi rst operation on the open human heart under direct vision—closure of an atrial septal defect (ASD) in a 5-year-old girl—was performed at the University ...

BACKGROUND Children with Down syndrome (DS) have about a 40 to 50% incidence of congenital heart disease (CHD). The objectives of this study were to evaluate the distribution and frequency of CHD patterns in Libyan children with DS. METHODS All patients with DS who were referred to the cardiology clinic between January 1995 and December 2008 were reviewed. RESULTS Of the 1 193 patients revi...

Percutaneous device closure for secundum atrial septal defects (ASDs) has been performed commonly and safely with high success rates. However, it is still challenging to close ASDs that are surrounded with deficient or hypermobile rims and could be compromised with an unexpected migration of device. We report a case of percutaneous Amplazter Septal Occluder (ASO; St. Jude Medical Inc., St. Paul...

BACKGROUND Secundum atrial septal defect is a common congenital heart disease. Amplatzer septal occluder has become the most commonly used device for its closure. This study was conducted to determine the safety and outcome of atrial septal defect closure with the Amplatzer septal occlude (ASO). METHODS This Case-series was conducted at Armed Forces Institute of Cardiology/National Institute ...